Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

HZNP | Horizon Therapeutics Plc

Healthcare | Drug Manufacturers - General | Ireland | NASD

Index	-	P/E	61.86	EPS (ttm)	1.87	Insider Own	1.05%	Shs Outstand	227.24M	Perf Week	0.20%
Market Cap	26.50B	Forward P/E	19.60	EPS next Y	5.91	Insider Trans	0.00%	Shs Float	226.59M	Perf Month	8.50%
Income	438.00M	PEG	12.37	EPS next Q	1.22	Inst Own	101.18%	Short Float / Ratio	4.19% / 4.26	Perf Quarter	12.69%
Sales	3.64B	P/S	7.27	EPS this Y	-1.94%	Inst Trans	1.83%	Short Interest	9.48M	Perf Half Y	6.02%
Book/sh	23.20	P/B	4.99	EPS next Y	23.93%	ROA	4.83%	Target Price	116.50	Perf Year	83.80%
Cash/sh	10.92	P/C	10.60	EPS next 5Y	5.00%	ROE	8.54%	52W Range	60.03 - 115.80	Perf YTD	1.70%
Dividend	-	P/FCF	27.66	EPS past 5Y	-	ROI	5.47%	52W High	-0.05%	Beta	1.03
Dividend %	-	Quick Ratio	3.86	Sales past 5Y	30.07%	Gross Margin	75.21%	52W Low	92.80%	ATR	0.62
Employees	2115	Current Ratio	4.05	Sales Q/Q	7.82%	Oper. Margin	14.77%	RSI (14)	82.08	Volatility	0.19% 0.32%
Optionable	Yes	Debt/Eq	0.51	EPS Q/Q	110.38%	Profit Margin	12.02%	Rel Volume	0.82	Prev Close	115.66
Shortable	Yes	LT Debt/Eq	0.51	Earnings	Aug 08 BMO	Payout	0.00%	Avg Volume	2.23M	Price	115.74
Recom	3.00	SMA20	0.79%	SMA50	7.60%	SMA200	7.29%	Volume	1,833,295	Change	0.07%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-01-22	Initiated	H.C. Wainwright	Neutral	$74
Aug-04-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Jun-14-22	Initiated	UBS	Buy	$139
Jun-06-22	Resumed	SVB Leerink	Mkt Perform	$95
May-23-22	Initiated	SVB Leerink	Mkt Perform	$95
Mar-15-22	Initiated	Oppenheimer	Outperform	$140
Dec-08-21	Initiated	Wells Fargo	Overweight	$137
Nov-19-21	Upgrade	Goldman	Neutral → Buy	$168
Oct-07-21	Resumed	Jefferies	Buy	$132
Mar-22-21	Resumed	Morgan Stanley	Overweight	$103
Mar-12-21	Initiated	Wolfe Research	Outperform	$107
Sep-09-20	Initiated	JP Morgan	Overweight	$110
Aug-27-20	Initiated	Citigroup	Buy	$112
Jan-08-20	Initiated	Goldman	Neutral	$35
Sep-26-19	Initiated	BofA/Merrill	Buy	$34
Sep-12-19	Initiated	Guggenheim	Buy
Aug-14-19	Upgrade	BMO Capital Markets	Market Perform → Outperform	$29 → $36
May-01-19	Upgrade	Citigroup	Neutral → Buy	$21 → $32
Mar-08-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$32
Nov-15-18	Downgrade	Mizuho	Buy → Neutral

Show Previous Ratings

Sep-26-23 09:02AM	Horizon Therapeutics plc Named to U.S. News & World Reports 2024 List of Best Companies to Work For in the Health Care Industry (Business Wire)
Sep-25-23 09:34AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
Sep-24-23 12:05AM	The Hedge Fund That Made a Killing Betting Against Lina Khan (The Wall Street Journal)
Sep-19-23 05:52PM	FTC chair targets deals that have fallen in agency's 'blind spots' (Yahoo Finance Video)
10:11AM	Healthcare: FTC Chair Lina Khan to crack down on 'below radar' deals (Yahoo Finance)
10:11AM	Loading…
10:11AM	Health care: FTC Chair Lina Khan to crack down on 'below radar' deals (Yahoo Finance)
09:57AM	Healthcare: FTC Chair Lina Khan to crack down on 'below radar' deals (Yahoo Finance Video)
08:00AM	Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List (Business Wire)
Sep-13-23 08:00AM	Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata (PR Newswire)
08:00AM	Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata (Business Wire)
Sep-12-23 09:22PM	The 3 Most Undervalued Biotech Stocks to Buy in September 2023 (InvestorPlace)
Sep-06-23 04:15PM	Horizon Therapeutics plc ("Horizon") Rule 2.12 Announcement (Business Wire)
08:00AM	Biden FTCs Antitrust Bark Proves Worse Than Its Bite (The Wall Street Journal)
Sep-05-23 09:05AM	Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement (Business Wire)
Sep-01-23 02:55PM	Amgens $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle (The Wall Street Journal)
11:03AM	Loading…
11:03AM	FTC Reaches Agreement With Amgen Over $27.8 Billion Deal for Horizon Therapeutics (The Wall Street Journal)
09:20AM	AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION (PR Newswire)
09:20AM	Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition (Business Wire)
09:18AM	FTC Settles With Amgen Over $27.8 Billion Deal for Horizon Therapeutics (The Wall Street Journal)
Aug-31-23 07:53AM	Is This the Green Light Biotech Stocks Have Been Waiting For? (Motley Fool)
Aug-28-23 11:42AM	FTC suspends challenge to Amgen-Horizon Therapeutics deal (Yahoo Finance Video) +5.14%
Aug-26-23 11:09AM	FTC Pauses Challenge to Amgens $27.8 Billion Deal for Horizon Therapeutics (The Wall Street Journal)
Aug-23-23 08:00AM	Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups (Business Wire)
Aug-09-23 10:30AM	Horizon Therapeutics plc - Rule 2.12 Announcement (Business Wire)
Aug-08-23 07:00AM	Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results (Business Wire)
Aug-04-23 04:09AM	Amgen raises full-year earnings and revenue outlook (Investing.com)
Jul-28-23 11:55AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:35AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:30AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:20AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:05AM	Loading…
11:05AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
10:55AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
Jul-27-23 08:00AM	Horizon Therapeutics plc Announces 2023 #RAREis Global Advocate Grant Recipients (Business Wire)
Jul-21-23 04:30PM	Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Daxdilimab for the Treatment of Systemic Lupus Erythematosus (SLE) Did Not Meet Primary Endpoint (Business Wire)
Jul-17-23 08:00AM	Horizon Therapeutics plc to Release Second-Quarter 2023 Financial Results on Aug. 8, 2023 (Business Wire)
Jul-06-23 08:00AM	Long-Term Data From the MIRROR Randomized Controlled Trial of KRYSTEXXA® (pegloticase) Injection With Methotrexate Published in ACR Open Rheumatology (Business Wire)
Jun-30-23 12:30PM	New Analysis of MRI Findings Shows UPLIZNA® (inebilizumab-cdon) Reduced the Formation of Subclinical Spinal Cord Lesions in People With Neuromyelitis Optica Spectrum Disorder (NMOSD) (Business Wire)
Jun-28-23 01:01PM	The New M&A Rules That Would Delay Million-Dollar Deals (Bloomberg)
Jun-26-23 11:00AM	TEPEZZA® (teprotumumab) Approved in Brazil for the Treatment of Active Thyroid Eye Disease (TED) (Business Wire)
Jun-22-23 08:00AM	Horizon Therapeutics plc Announces Positive Topline Data from Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Active Thyroid Eye Disease (TED) (Business Wire)
Jun-17-23 05:00PM	Additional Data from Phase 4 TEPEZZA® (teprotumumab-trbw) Clinical Trial Presented at the Endocrine Society Annual Meeting Reinforces Efficacy in People with Thyroid Eye Disease (TED) Regardless of Disease Activity or Duration (Business Wire)
02:00PM	New Data from TEPEZZA® (teprotumumab-trbw) Clinical Trials and Real-World Analyses Shed Light on Link Between Thyroid Autoimmunity and Hearing Risks (Business Wire)
Jun-12-23 07:00PM	Horizon Therapeutics plc ("Horizon") Rule 2.12 Announcement (Business Wire)
08:00AM	UPLIZNA® (inebilizumab-cdon) Pivotal Trial Publication Integrating MRI and Biomarker Evaluation Shows Accuracy and Uniformity of Attack Diagnoses for Neuromyelitis Optica Spectrum Disorder (NMOSD) (Business Wire)
Jun-08-23 04:13PM	15 Healthcare Stocks Billionaires Are Loading Up On (Insider Monkey)
Jun-06-23 07:00AM	Horizon Therapeutics plc announces premium partnership with KPMG Womens Irish Open (Business Wire)
Jun-05-23 08:00AM	Horizon Therapeutics plc Announces Data from the TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low CAS Thyroid Eye Disease (TED) to be Presented at the Upcoming Endocrine Society (ENDO) Annual Meeting (Business Wire)
Jun-02-23 11:50AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:40AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:30AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
07:55AM	3 Undervalued Biotech Stocks to Buy Before They Blast Off (InvestorPlace)
Jun-01-23 12:00PM	Is Amgen a Good Dividend Stock? (Motley Fool)
08:00AM	Biomarker Analysis Publication Highlights Key Signals of Disability Worsening Associated With Neuromyelitis Optica Spectrum Disorder (NMOSD) Attacks, Illustrates Efficacy of UPLIZNA® (inebilizumab-cdon) (Business Wire)
May-31-23 08:10AM	Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögrens Syndrome (Business Wire)
08:00AM	New Analyses of the MIRROR Randomized Controlled Trial in Uncontrolled Gout Presented at the 2023 EULAR European Congress of Rheumatology (Business Wire)
May-25-23 11:21AM	Top 10 Billionaire Stocks From 10 Billionaires (Insider Monkey)
May-23-23 08:00AM	Horizon Therapeutics plc Announces Presentation of Data that Advances the Understanding of Rheumatic Diseases at the 2023 EULAR European Congress of Rheumatology (Business Wire)
May-21-23 05:19AM	4 big deal reports: Amgen-Horizon merger on the ropes (Investing.com)
May-17-23 04:26PM	Fed, labor market concerns showing 'some dents in the armor of the consumer': Strategist (Yahoo Finance Video)
05:13AM	FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks? (Motley Fool)
May-16-23 05:24PM	FTC Moves to Block Amgens $27.8 Billion Deal for Horizon Therapeutics (The Wall Street Journal) -14.17%
05:08PM	Home Depot, FTC blocks Amgen deal, Comcast's Hulu stake: Tuesday's top headlines (Yahoo Finance Video)
04:21PM	Lowe's, Horizon Therapeutics, AMD: Stocks moving ahead of the close (Yahoo Finance Video)
04:05PM	Stocks to Watch Tuesday: Capital One, Horizon Therapeutics, Home Depot (The Wall Street Journal)
03:33PM	FTC sues to block Amgen's $27.8 billion deal to acquire Horizon Therapeutics (Yahoo Finance Video)
02:40PM	Horizon Therapeutics Stock Plunges as FTC Plans to Block Amgen Deal (The Wall Street Journal)
12:36PM	Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday (Motley Fool)
11:46AM	Horizon Therapeutics plc Responds to U.S. Federal Trade Commission (FTC) Action to Block Acquisition by Amgen (Business Wire)
11:21AM	FTC sues to block Amgen's $28B acquisition of Horizon Therapeutics (Yahoo Finance)
11:14AM	Why Horizon Therapeutics Stock Is Crashing Today (Motley Fool)
10:57AM	FTC Poised to Block Amgens $27.8 Billion Deal for Horizon Therapeutics (The Wall Street Journal)
09:52AM	FTC to challenge Amgen's $28 billion deal with Horizon Therapeutics: Report (Yahoo Finance Video)
May-10-23 11:30AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
May-09-23 08:00AM	Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by U.S. Patient Advocacy Groups (Business Wire)
May-03-23 06:27PM	Why Amgen Stock Was Sickly Today (Motley Fool)
07:00AM	Horizon Therapeutics plc Reports First-Quarter 2023 Financial Results (Business Wire)
May-02-23 09:25AM	Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Lupus Nephritis (Business Wire)
08:00AM	Horizon Therapeutics plc Ranks First in Patient Centricity and Integrity by Patient Advocacy Groups According to New PatientView Survey (Business Wire)
May-01-23 11:59AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:55AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:50AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:42AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
11:37AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
08:00AM	Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in Japan Evaluating TEPEZZA® (teprotumumab-trbw) in Adults with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED) (Business Wire)
Apr-27-23 07:15AM	Aristotle Atlantic Focus Growth Sold Horizon Therapeutics Public Limited Company (HZNP) on Acquisition News (Insider Monkey)
Apr-20-23 08:00AM	Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting (Business Wire)
Apr-18-23 08:00AM	Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community (Business Wire)
Apr-17-23 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
08:08AM	Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement (Business Wire)
Apr-14-23 08:15AM	Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration (Business Wire)
08:00AM	Horizon Therapeutics plc to Release First-Quarter 2023 Financial Results on May 3, 2023 (Business Wire)
Apr-10-23 08:00AM	Horizon Therapeutics plc Announces Positive Topline Data from TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED) (Business Wire)
Apr-06-23 03:53AM	Horizon Therapeutics Public Limited Company (HZNP) Rose in Q4 on Acquisition News (Insider Monkey)
Apr-04-23 08:00AM	Horizon Therapeutics plc Named to the 2023 Fortune 100 Best Companies to Work For List (Business Wire)
Mar-23-23 03:09AM	Should You Invest in Horizon Therapeutics Public Limited Company (HZNP)? (Insider Monkey)
Mar-17-23 09:45AM	Here's Why Horizon Therapeutics (HZNP) is a Strong Growth Stock (Zacks)
Mar-16-23 11:55AM	Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) (Business Wire)
Mar-14-23 11:15AM	New Analysis of MRI Findings Show UPLIZNA® (inebilizumab-cdon) Reduced the Formation of Asymptomatic Optic Nerve Lesions in People With Neuromyelitis Optica Spectrum Disorder (NMOSD) (Business Wire)
Mar-12-23 12:00PM	Real-World Experience Shows TEPEZZA® (teprotumumab-trbw) Was Effective in Treating People With Dysthyroid Optic Neuropathy (DON) (Business Wire)
Mar-03-23 06:30AM	7 Over-$100 Stocks That Are Worth Every Penny (InvestorPlace)

Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SANTINI GINO	Director	Sep 22	Option Exercise	15.96	20,000	319,200	77,867	Sep 25 07:07 PM
DesJardin Michael A.	EVP, Technical Operations	Mar 02	Option Exercise	15.31	4,372	66,953	126,558	Mar 06 04:48 PM
Pasternak Andy	EVP, Chief Strategy Officer	Jan 17	Sale	113.03	27,129	3,066,323	56,338	Jan 18 04:19 PM
Cox Aaron	EVP, Chief Financial Officer	Jan 13	Sale	113.17	36,148	4,090,847	277	Jan 17 08:32 PM
SHERMAN JEFFREY W	EVP and Chief Medical Officer	Jan 11	Sale	113.10	3,368	380,921	36,171	Jan 12 04:29 PM
SHERMAN JEFFREY W	EVP and Chief Medical Officer	Jan 10	Sale	113.05	3,368	380,752	39,539	Jan 12 04:29 PM
SHERMAN JEFFREY W	EVP and Chief Medical Officer	Jan 06	Sale	113.29	5,187	587,635	49,314	Jan 06 05:54 PM
Pasternak Andy	EVP, Chief Strategy Officer	Dec 13	Option Exercise	29.52	23,251	686,370	64,216	Dec 14 05:10 PM
Pasternak Andy	EVP, Chief Strategy Officer	Dec 13	Sale	112.60	30,169	3,397,171	34,047	Dec 14 05:10 PM
SHERMAN JEFFREY W	EVP and Chief Medical Officer	Dec 12	Sale	111.45	28,352	3,159,692	54,501	Dec 13 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HZNP | Horizon Therapeutics Plc

Upgrade your FINVIZ experience